Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic Challenge
Balraj Singh(The University of Texas MD Anderson Cancer Center), Anthony Lucci(The University of Texas MD Anderson Cancer Center)
Cited by 137
Related Papers
Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine
|Oncotarget|2021|18
Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential
|Oncotarget|2019|12